Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebekka Kleiner

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Therapeutische Umschau. Revue Therapeutique|February 18, 2016
[Sarcoidosis--a multisystem disorder with variable prognosis]Rebekka Kleiner, Martin Brutsche
Therapeutische Umschau. Revue Therapeutique|April 24, 2024
[Progressive pulmonary Fibrosis]Rebekka Kleiner, Susanne Pohle
International Journal of Cardiology|September 25, 2015
Severely worsening dyspnea after initiation of macitentan therapy for pulmonary arterial hypertensionMicha T Maeder, Rebekka Kleiner, Daniel Weilenmann
Swiss Medical Weekly|November 1, 2018
Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trialKatrin Hostettler, Florent Baty, Rebekka Kleiner, et al.
Swiss Medical Weekly|January 20, 2017
Pulmonary hypertension associated with left-sided heart diseaseMicha Tobias Maeder, Otto D Schoch, Rebekka Kleiner, et al.
Respiration; International Review of Thoracic Diseases|March 27, 2017
Idiopathic Pulmonary Fibrosis in Switzerland: Diagnosis and TreatmentManuela Funke-Chambour, Andrea Azzola, Dan Adler, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Therapeutische Umschau. Revue Therapeutique|February 18, 2016
[Sarcoidosis--a multisystem disorder with variable prognosis]Rebekka Kleiner, Martin Brutsche
Therapeutische Umschau. Revue Therapeutique|April 24, 2024
[Progressive pulmonary Fibrosis]Rebekka Kleiner, Susanne Pohle
International Journal of Cardiology|September 25, 2015
Severely worsening dyspnea after initiation of macitentan therapy for pulmonary arterial hypertensionMicha T Maeder, Rebekka Kleiner, Daniel Weilenmann
Swiss Medical Weekly|November 1, 2018
Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trialKatrin Hostettler, Florent Baty, Rebekka Kleiner, et al.
Swiss Medical Weekly|January 20, 2017
Pulmonary hypertension associated with left-sided heart diseaseMicha Tobias Maeder, Otto D Schoch, Rebekka Kleiner, et al.
Respiration; International Review of Thoracic Diseases|March 27, 2017
Idiopathic Pulmonary Fibrosis in Switzerland: Diagnosis and TreatmentManuela Funke-Chambour, Andrea Azzola, Dan Adler, et al.
Pageof 1